STAT+: GSK sees its return to cancer start to pay off
· statnews.com · popularity 33/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at statnews.com →
Summary
A decade ago, GSK was out of oncology. It could soon pick up approval for its sixth cancer drug.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 5.